Yosra M Aljawai

21PUBLICATIONS
52CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 31, 2026
Phase I/II Trial of Evomela for Autologous Transplant in Myeloma: Schedule Optimization and Matched Comparison with MEL200.

|Jul 24, 2026
Prognostic impact of monosomy 13 and deletion of 13q in multiple myeloma patients undergoing upfront autologous transplantation.

|Jul 06, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.

|May 13, 2026
Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant.

|Mar 10, 2026
Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamide.

Portia Smallbone, Kai Cao, Rima M Saliba

|Jan 13, 2026
Re-Evaluating Donor Selection Priorities for Hematopoietic Cell Transplantation With Post-Transplant Cyclophosphamide.

Rohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei

Pageof 4

Frequent Collaborators

10 joint publications

Jeremy Ramdial

10 joint publications

Yago Nieto

9 joint publications

Rohtesh S Mehta

9 joint publications

Richard E Champlin